198 related articles for article (PubMed ID: 2810381)
1. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
Hall ED; Yonkers PA; Horan KL; Braughler JM
J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
[TBL] [Abstract][Full Text] [Related]
2. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
Hall ED
J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
[TBL] [Abstract][Full Text] [Related]
3. A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.
Hall ED; Wolf DL
J Neurosurg; 1986 Jun; 64(6):951-61. PubMed ID: 3084721
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord.
Hall ED; Yonkers PA; Taylor BM; Sun FF
J Neurotrauma; 1995 Jun; 12(3):245-56. PubMed ID: 7473799
[TBL] [Abstract][Full Text] [Related]
5. Effect of delayed administration of U74006F (tirilazad mesylate) on recovery of locomotor function after experimental spinal cord injury.
Anderson DK; Hall ED; Braughler JM; McCall JM; Means ED
J Neurotrauma; 1991; 8(3):187-92. PubMed ID: 1803027
[TBL] [Abstract][Full Text] [Related]
6. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis.
Hall ED; Wolf DL; Braughler JM
J Neurosurg; 1984 Jul; 61(1):124-30. PubMed ID: 6374068
[TBL] [Abstract][Full Text] [Related]
7. Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats.
Farooque M; Olsson Y; Holtz A
Acta Neurol Scand; 1994 Jan; 89(1):36-41. PubMed ID: 8178626
[TBL] [Abstract][Full Text] [Related]
8. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
[TBL] [Abstract][Full Text] [Related]
9. The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.
McIntosh TK; Thomas M; Smith D; Banbury M
J Neurotrauma; 1992; 9(1):33-46. PubMed ID: 1619674
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs.
Perkins WJ; Milde LN; Milde JH; Michenfelder JD
Stroke; 1991 Jul; 22(7):902-9. PubMed ID: 1853410
[TBL] [Abstract][Full Text] [Related]
11. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F.
Holtz A; Gerdin B
J Neurotrauma; 1991; 8(4):239-45. PubMed ID: 1803032
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
Stanley JJ; Goldblum JR; Frank TS; Zelenock GB; D'Alecy LG
J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
[TBL] [Abstract][Full Text] [Related]
13. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion.
Carrea FP; Lesnefsky EJ; Kaiser DG; Horwitz LD
J Cardiovasc Pharmacol; 1992 Aug; 20(2):230-5. PubMed ID: 1381014
[TBL] [Abstract][Full Text] [Related]
14. The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke.
Wilson JT; Bednar MM; McAuliffe TL; Raymond S; Gross CE
Neurosurgery; 1992 Nov; 31(5):929-33; discussion 933-4. PubMed ID: 1436419
[TBL] [Abstract][Full Text] [Related]
15. Effect of a calcium channel blocker on posttraumatic spinal cord blood flow.
Guha A; Tator CH; Piper I
J Neurosurg; 1987 Mar; 66(3):423-30. PubMed ID: 3819838
[TBL] [Abstract][Full Text] [Related]
16. Post-traumatic spinal cord ischemia: relationship to injury severity and physiological parameters.
Hall ED; Wolf DL
Cent Nerv Syst Trauma; 1987; 4(1):15-25. PubMed ID: 3607898
[TBL] [Abstract][Full Text] [Related]
17. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
Umemura K; Wada K; Uematsu T; Mizuno A; Nakashima M
Eur J Pharmacol; 1994 Jan; 251(1):69-74. PubMed ID: 8137871
[TBL] [Abstract][Full Text] [Related]
18. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
Yue G; Sun FF; Dunn C; Yin K; Wong PY
J Pharmacol Exp Ther; 1996 Jan; 276(1):265-70. PubMed ID: 8558441
[TBL] [Abstract][Full Text] [Related]
19. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury.
Sato PH; Hall ED
J Neurochem; 1992 Jun; 58(6):2263-8. PubMed ID: 1573405
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.
Hall ED; Yonkers PA
Stroke; 1988 Mar; 19(3):340-4. PubMed ID: 3354019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
